Dr. Rohit Shamrao Mulik
Post-doctoral FellowUniversity of Texas Southwestern Medical Center, USA
Highest Degree
Ph.D. in Pharmaceutics from Bharati Vidyapeeth University, India
Share this Profile
University of Texas Southwestern Medical Center, USA
Biography
Dr. Rohit Shamrao Mulik is currently working as Senior Postdoctoral Researcher II at Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. He obtained his PhD in Pharmaceutics from Bharati Vidyapeeth University, Pune, India in 2010. In past he worked as Senior Research Fellow at Bharati Vidyapeeth University, SITRA Research Fellow at University of Eastern Finland, Kuopio Finland, Postdoctoral Associate at University of Hawaii at Hilo, Hawaii, USA, and Senior Executive at Panacea Biotec Ltd., Navi Mumbai, India. He is professional member of Controlled Release Society Indian Local Chapter, American Association of Pharmaceutical Scientists, USA. He is also serving as reviewer in number of international journals, and also member of editorial board. He has published 9 articles in journals and 10 presentations in national and international journals. He also attended number of workshops and seminars.
Area of Interest:
Pharmacology and Toxicology
100%
Drug Delivery
62%
Pharmaceutics
90%
Nanomedicine
75%
Flow Cytometry
55%
Research Publications in Numbers
Books
0
0
Chapters
0
0
Articles
0
0
Abstracts
0
0
Selected Publications
- Reynolds, L., R.S. Mulik, X. Wen, A. Dilip and I.R. Corbin, 2014. Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells. Nanomedicine, 9: 2123-2141.
CrossRef | Direct Link | - Youngren, S.R., R.S. Mulik, B. Jun, P.R. Hoffmann, K.R. Morris and M.B. Chougule, 2013. Freeze-dried targeted mannosylated selenium-loaded nanoliposomes: Development and evaluation. AAPS PharmSciTech., 14: 1012-1024.
CrossRef | Direct Link | - Mulik, R.S., J. Monkkonen, R.O. Juvonen, K.R. Mahadik and A.R. Paradkar, 2012. Apoptosis-induced anticancer effect of transferrin-conjugated solid lipid nanoparticles of curcumin. Cancer Nanotechnol., 3: 65-81.
CrossRef | Direct Link | - Mulik, R.S., J. Monkkonen, R.O. Juvonen, K.R. Mahadik and A.R. Paradkar, 2012. ApoE3 mediated polymeric nanoparticles containing curcumin: Apoptosis induced in vitro anticancer activity against neuroblastoma cells. Int. J. Pharm., 437: 29-41.
CrossRef | PubMed | Direct Link | - Rupali, K., R.S. Mulik, L. Badgujar, A.R. Paradkar, K.R. Mahadik and S.L. Bodhankar, 2010. Development and characterization of microemulsion formulations for transdermal delivery of aceclofenac: A research. Int. J. Drug Formulat. Res., 1: 359-386.
- Mulik, R.S., J. Monkkonen, R.O. Juvonen, K.R. Mahadik and A.R. Paradkar, 2010. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: Study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model. Mol. Pharm., 7: 815-825.
CrossRef | PubMed | Direct Link | - Mulik, R.S., V. Kulkarni and R.S.R. Murthy, 2009. Chitosan-based thermosensitive hydrogel containing liposomes for sustained delivery of cytarabine. Drug Dev. Ind. Pharm., 35: 49-56.
CrossRef | PubMed | Direct Link | - Mulik, R.S., K. Mahadik and A. Paradkar, 2009. Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: Physicochemical characterization and stability study. Eur. J. Pharm. Sci., 37: 395-404.
CrossRef | PubMed | Direct Link | - Mulik, R.S., J. Monkkonen, R.O. Juvonen, K.R. Mahadik and A.R. Paradkar, 2007. Transferrin mediated solid lipid nanoparticles containing curcumin: Enhanced in vitro anticancer activity by induction of apoptosis. Int. J. Pharm., 398: 190-203.
CrossRef | PubMed |